title: Haploidentical transplantation with post-transplant cyclophosphamide following reduced-intensity conditioning for osteopetrosis: outcomes in three children.
authors.affiliation: Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.
authors.forename: T L
authors.initials: TL
authors.lastname: Bahr
authors.affiliation: Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, USA.
authors.forename: T
authors.initials: T
authors.lastname: Lund
authors.affiliation: Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, USA.
authors.forename: N M
authors.initials: NM
authors.lastname: Sando
authors.affiliation: Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, USA.
authors.forename: P J
authors.initials: PJ
authors.lastname: Orchard
authors.affiliation: Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, USA.
authors.forename: W P
authors.initials: WP
authors.lastname: Miller
mesh_terms: D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006085:Graft Survival; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D008297:Male; D010022:Osteopetrosis / Q000628:therapy*; D019172:Transplantation Conditioning / Q000379:methods*; D000075442:Transplantation, Haploidentical / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide